|
As a strategic
goal, liaison with other European and International organisations
in the area of pharmaceutical sciences is essential for EUFEPS.
EUFEPS co-sponsors,
and participates in the scientific programme of the World Congress
in Pharmaceutical Sciences, and is organising the World Conference
on Drug Absorption and Drug Delivery. Other initiatives include
the innovative
annual Optimising Drug Development conference series, the New
Safe Medicines Faster project aimed at the EU 6th RTD Framework
Programme, educational and training programmes, as well as the
biennial Congresses in the Pharmaceutical Sciences, which bring
together European scientists from all the disciplines comprising
the pharmaceutical sciences.
Formal and informal
relationships with other organisations include:
Pharmaceutical Sciences
- American Association
of Pharmaceutical Scientists (AAPS)
- American Society
of Clinical Pharmacology & Therapeutics (ASCPT)
- European Association
of Clinical Pharmacology and Therapeutics (EACPT)
- FIP Board of Pharmaceutical
Sciences (FIP BPS)
- International Society
for the Study of Xenobiotics (ISSX)
Drug Development
- Center for Drug
Development Science (CDDS),
Washington, DC USA
- European Center
of Pharmaceutical Medicine (ECPM),
Basel, Switzerland
- European Co-operation
in the Field of Scientific and Technical Research/Medical Research/Modelling
during drug development (COST B15)
- European Federation
of Pharmaceutical Industries and Associations (EFPIA),
Brussels, Belgium
- Leiden/Amsterdam
Centre for Drug Research (LACDR),
Leiden, The Netherlands
- Tufts Center for
the Study of Drug Development (CSDD),
Boston, MA USA.
Regulatory Bodies
The European Medicines
Evaluation Agency (EMEA).
It has recognised EUFEPS as an independent Pan-European scientific
sounding board.
US Food and Drug Administration Center for Drug Evaluation and
Research (FDA CDER).
A good working relationship is in place as an active FDA Liaison
Officer to EUFEPS (Dr Lawrence J. Lesko, PhD) was appointed.
European Union
E´EUFEPS has developed relations with the EU on the level
of the Commission, and EUFEPS has an active Liaison Officer to
European Affairs (Professor Ole J. Bjerrum, Danish University
of Pharmaceutical Science, Copenhagen, Denmark). This gives short
access to early information on further developments of the EU
Research Programme, particularly, but also to other relevant and
important Europan collaboration matters and issues.
|
